“…The following excipients were from commercial sources: HPMCAS-MF (Shin-Etsu Co. Ltd, Tokyo, Japan), company), PVPVA (BASF, Ludwigshaven, Germany), HPC (Ashland Inc., Covington, Kentucky), PVP K29/32 (BASF, Ludwigshaven, Germany), and Labrasol ALF (Gattefosse, Lyon, France). The novel cellulose derivatives were synthesized as described previously (abbreviations defined and compositions given in Table 1 ): CPHPC-106 25 , CPHPC-282 25 , CPHPC-069 25 , CPTod-202 11 , CAAd PEG 11 , CAAd HOEt 11 , CAAdP 0.85 36 , CAAd 0.67 36 , CA Sub 36 , CAAd 3CES HE 11 , CAUn 3CES TAE 11 , MC-Ad 24 , MCCP-A 24 , MCCP-B 24 , ECCP-A 24 , ECCP-B 24 , ECCP-C 24 , and ECCP-D 24 . Enzalutamide was obtained from ChemShuttle (Hayward, California).…”